Estuary Capital Management LP Makes New $49.91 Million Investment in UnitedHealth Group Incorporated $UNH

Key Points

• Estuary Capital Management LP made a new investment in UnitedHealth Group shares, purchasing 95,300 shares valued at approximately $49.91 million, which now accounts for 12.1% of its investment portfolio.
• UnitedHealth Group's CEO Patrick Hugh Conway sold 589 shares for about $179,645, reducing his ownership by 5.36% to 10,398 shares valued at approximately $3.17 million.
• Analysts have recently downgraded UnitedHealth Group's stock ratings, with some issuing a "strong sell", while the average price target is set at $353.00, reflecting mixed sentiment among market experts.

Estuary Capital Management LP bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 1st quarter, according to the company in its most recent filing with the SEC. The fund bought 95,300 shares of the healthcare conglomerate's stock, valued at approximately $49,913,000. UnitedHealth Group accounts for about 12.1% of Estuary Capital Management LP's investment portfolio, making the stock its 2nd largest position.

Other institutional investors and hedge funds have also modified their holdings of the company. Bayforest Capital Ltd grew its holdings in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after acquiring an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd grew its holdings in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after acquiring an additional 50 shares during the period. Copia Wealth Management purchased a new stake in UnitedHealth Group in the 4th quarter valued at approximately $42,000. IAG Wealth Partners LLC purchased a new stake in UnitedHealth Group in the 1st quarter valued at approximately $42,000. Finally, Investment Management Corp VA ADV purchased a new stake in UnitedHealth Group in the 4th quarter valued at approximately $44,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares of the company's stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.28% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. Baird R W lowered UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research note on Thursday, July 31st. Wall Street Zen lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Wolfe Research reduced their price target on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 20th. Royal Bank Of Canada reduced their price target on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Finally, Bank of America increased their price target on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research note on Monday, August 18th. Fifteen analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $353.00.

UnitedHealth Group Stock Down 0.5%

Shares of NYSE UNH opened at $307.27 on Thursday. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The company has a market cap of $278.29 billion, a P/E ratio of 13.31, a P/E/G ratio of 2.00 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a fifty day moving average price of $288.51 and a 200 day moving average price of $377.17.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's revenue was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's payout ratio is 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.